Pathogenesis and management of Kawasaki disease - Wikidata - wikimedia - TriplyDB

Pathogenesis and management of Kawasaki disease

Pathogenesis and management of Kawasaki disease

http://www.wikidata.org/entity/Q22305933

about

Kawasaki Disease: A Clinician's Update Application of prospective ECG-triggered dual-source CT coronary angiography for infants and children with coronary artery aneurysms due to Kawasaki disease.A heart-breaking case of fever and rash Kawasaki disease: laboratory findings and an immunopathogenesis on the premise of a "protein homeostasis system".Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Profiles of responses of immunological factors to different subtypes of Kawasaki disease.Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease.Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.Concurrent adrenal neuroblastoma and kawasaki disease: a report of a rare case Superantigen involvement and susceptibility factors in Kawasaki disease: profiles of TCR Vβ2+ T cells and HLA-DRB1, TNF-α and ITPKC genes among Filipino patients.Acetylsalicylic acid for children with Kawasaki disease.Co-morbidity of Kawasaki disease.A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.L’acide acétylsalicylique pour les enfants atteints de la maladie de Kawasaki.The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease.Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease.Controversies in diagnosis and management of Kawasaki disease.Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.A meta-analysis of the biomarkers associated with coronary artery lesions secondary to Kawasaki disease in Chinese children.Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).Regulatory T cell microRNA expression changes in children with acute Kawasaki disease.Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.A 3-month-old infant with atypical Kawasaki disease.

P2860

Q26998791-21269249-978A-4970-A744-EDAE03F81490 Q30446491-51AECE31-A059-4494-8794-FC72C3D858D8 Q34071462-C6BE7141-AA9A-4DB1-8F7C-E97451CDC351 Q34253124-680EFA07-D57E-4F5C-8DFF-ACB0E890ADDA Q35184950-B03C1CA3-0F9D-4614-B6F1-E455E5B71583 Q35752608-290C5753-FC00-46BD-9EA4-8554B87E555F Q35819600-5C08F7F0-AEC1-43B7-87FD-DBC28D2C1D60 Q36660337-4C2E7F1A-DB62-47DB-AD9B-A11E92134A3B Q37239530-91ED5B0F-E58A-4405-BFD8-A99503F413C9 Q37364378-9D73C664-3D83-4D82-8538-55E4A52C6292 Q38087960-A3825790-15C3-4356-BEDA-47B55F744374 Q39447395-8F34C86D-3702-45FC-BB6C-E8BD63B37D54 Q40043358-D71F0D70-19AC-4A3A-8F5E-2FDD24880293 Q40306788-9048EE3B-ED31-41D6-B610-B6C02C28525C Q40311553-8D80F7F6-E569-4CD4-8533-D2A2E58DDA9F Q41379432-AB45BDBA-BAA0-45BF-B940-81C2A5EE46F7 Q45909002-D37080FE-FB41-4B05-A7C8-900054D7D5B6 Q47134975-ABFC8860-CF4A-4023-A201-5F60B2ED6C9E Q49873428-49BF3C07-BED0-4599-835A-29A53173C69A Q50218487-3734E1AA-AF4E-4BA6-82CD-241CB309F5D2 Q53090633-67A77825-22A7-4C83-A7A3-8A7CBE12A4CB Q54144614-C83B0ED1-B811-4FDF-9A4B-D9D1175373D6 Q54198415-025FEC15-9D1F-4C14-9778-346CF06D8941 Q54276724-2EDAC124-448F-47D7-B0F4-2F42867BFD4E Q55339665-AF7B5272-32C7-486A-9E40-E6381ADB3D2F

P2860

Pathogenesis and management of Kawasaki disease

http://www.wikidata.org/entity/Q22305933

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Pathogenesis and management of Kawasaki disease

@ast

Pathogenesis and management of Kawasaki disease

@en

Pathogenesis and management of Kawasaki disease

@en-gb

Pathogenesis and management of Kawasaki disease

@nl

type

label

Pathogenesis and management of Kawasaki disease

@ast

Pathogenesis and management of Kawasaki disease

@en

Pathogenesis and management of Kawasaki disease

@en-gb

Pathogenesis and management of Kawasaki disease

@nl

prefLabel

Pathogenesis and management of Kawasaki disease

@ast

Pathogenesis and management of Kawasaki disease

@en

Pathogenesis and management of Kawasaki disease

@en-gb

Pathogenesis and management of Kawasaki disease

@nl

P1433

Q22305933-B3A56F22-CAA8-416F-9AAE-4161E2B53DE1

P1476

Q22305933-0EA06C44-3B20-478C-9D76-6156035927EA

P2093

Q22305933-BCA73DEB-D5BE-4241-99DF-34363076717F

Q22305933-E762BCEB-2BB3-46A9-AED7-97C0B8B41830

P2860

Q22305933-01100F21-DF9F-44B7-9B88-57A81B06004B

Q22305933-0C3518A1-DAC3-4729-A805-C8F20A25510F

Q22305933-1C06DB34-2E67-4A21-B375-FBBAC98B6B59

Q22305933-1DFA84EC-0DF0-403A-B0EE-510C209909CE

Q22305933-24DA48B7-8F34-4A76-B563-E318227AD011

Q22305933-3B16CDA3-4251-4526-8DBC-A71CA809188C

Q22305933-40679FB2-D1BC-48C6-A1AC-0B1F01D12BE9

Q22305933-43DE87F0-04B2-4C9F-BD37-8AF98890403E

Q22305933-442CA058-A7BC-4BD7-B581-819044B26B88

Q22305933-45474391-8753-4771-B7DB-68CC4A9D9836

P304

Q22305933-A374D3D7-9A22-49EF-8965-0E55718D8851

P31

Q22305933-2F56C816-5688-4B42-BDE7-D3E8378E0D09

P3181

Q22305933-2FBF286F-1694-413D-BCA6-B09A0C708113

P356

Q22305933-E01D5EC3-C2F9-4851-9CEB-6739AC7658B1

P407

Q22305933-B71E8E01-CA91-42E8-A91B-3CA7F7AE1DC8

P433

Q22305933-C53A6E5A-47C4-4B41-9293-85BD78D6F993

P478

Q22305933-73C6FACA-C20C-48D1-9495-9BAB4D9F5372

P577

Q22305933-9592460E-B6F5-46CD-B1F5-9F40C3078332

P5875

Q22305933-57435CA7-AA44-493D-9B29-E3D49E71C8E0

P698

Q22305933-01528934-877C-4D9E-97E0-93FFD2AC995A

P921

Q22305933-AAED10E7-9B48-4CF4-B227-2D68231978C7

P932

Q22305933-D0785D4C-BDC3-4355-9207-CF1FB585C498

P3181

P356

P1433

Expert Review of Anti-infective Therapy

P1476

Pathogenesis and management of Kawasaki disease

@en

P2093

Anne H Rowley

http://www.w3.org/2001/XMLSchema#string

Stanford T Shulman

http://www.w3.org/2001/XMLSchema#string

P2860

A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease

ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms

Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease

Refractory Kawasaki disease

Infliximab treatment for refractory Kawasaki syndrome

Early treatment with intravenous immunoglobulin in patients with Kawasaki disease

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Associ

Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease

Oligoclonal IgA response in the vascular wall in acute Kawasaki disease.

IgA plasma cells in vascular tissue of patients with Kawasaki syndrome.

P304

197-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3515815

http://www.w3.org/2001/XMLSchema#string

P356

10.1586/ERI.09.109

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41172370

http://www.w3.org/2001/XMLSchema#string

P698

20109049

http://www.w3.org/2001/XMLSchema#string

P921

P932

2845298

http://www.w3.org/2001/XMLSchema#string